Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Barry Kapik"'
Autor:
Barry Kapik, Debra A. Goldstein, Quan Dong Nguyen, Rahul N. Khurana, Mark R. Barakat, Thomas A. Ciulla, Thomas A. Albini, Emmett T. Cunningham, Dilraj S. Grewal
Publikováno v:
American Journal of Ophthalmology. 237:310-324
PURPOSE To assess the relationship between best corrected visual acuity (BCVA) and central subfield optical coherence tomography (OCT) features in noninfectious uveitis (NIU)-related macular edema (ME). DESIGN Clinical cohort study from post hoc anal
Autor:
Steven Yeh, Pauline T. Merrill, Barry Kapik, Michael A Singer, Thomas A. Ciulla, Colette Hall
Publikováno v:
Clinical & Experimental Ophthalmology. 50:23-30
Background This post hoc analysis compared the efficacy and safety of CLS-TA to other commonly available treatments for noninfectious uveitis (NIU). Methods Results from the PEACHTREE study were compared between subjects randomized to CLS-TA not requ
Autor:
Barry Kapik, Faruque Ghanchi, Daniel M. Miller, Craig M. Greven, Baruch D. Kuppermann, Michael A Singer, Clare Bailey, Jeffrey G. Gross
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 49:698-706
BACKGROUND AND OBJECTIVE: Visual outcomes of the FAME study (0.2 μg/day fluocinolone acetonide [FAc]) and Protocol I (0.5 mg ranibizumab plus deferred laser) were compared using the area under the curve (AUC) analysis method. PATIENTS AND METHODS: B
Autor:
Thomas A. Ciulla, Eric B. Suhler, Milan Shah, Mark R Barakat, Pauline T. Merrill, Christopher R. Henry, Robert C Wang, Barry Kapik, Eduardo Uchiyama, Steven Yeh, Rahul N. Khurana
Publikováno v:
British Journal of Ophthalmology. :bjophthalmol-2020
PurposeTo assess the extended efficacy and safety of suprachoroidal triamcinolone acetonide injectable suspension (CLS-TA) among patients with macular oedema (ME) secondary to non-infectious uveitis (NIU).MethodsPatients with uveitic ME were treated
Publikováno v:
Advances in Therapy. 19:161-169
Ketotifen fumarate, formulated for the treatment of allergic conjunctivitis, is a histamine H1-receptor antagonist, mast cell stabilizer, and eosinophil inhibitor (decreases chemotaxis and activation of eosinophils). In this study, healthy volunteers
Autor:
Kane Frances Elizabeth, Elias Reichel, Ken Green, David M. Brown, Sanford Chen, José M. Ruiz-Moreno, David S. Boyer, Peter A. Campochiaro, Clare Bailey, Andrew Pearson, Bruce R. Garretson, Kathleen Billman, Seenu M. Hariprasad, Gisèle Soubrane, Barry Kapik, Amod Gupta
Publikováno v:
Ophthalmology. 119(10)
Objective To assess long-term efficacy and safety of intravitreal inserts releasing 0.2 μg/d (low dose) or 0.5 μg/d (high dose) fluocinolone acetonide (FAc) in patients with diabetic macular edema (DME). Design Two randomized, sham injection-contro
Autor:
L. Duarte, Andrew Pearson, John R. Gonder, Kathleen Billman, Kane Frances Elizabeth, David S. Boyer, Steven A. Madreperla, Frank G. Holz, Barry Kapik, Peter A. Campochiaro, Michael J. Tolentino, Amod Gupta, Thomas A. Ciulla, David M. Brown
Publikováno v:
Ophthalmology. 118:626-635.e2
Objective To assess the efficacy and safety of intravitreal inserts releasing 0.2 μg/day (low dose) or 0.5 μg/day (high dose) fluocinolone acetonide (FA) in patients with diabetic macular edema (DME). Design Two parallel, prospective, randomized, s